Lisata Therapeutics, Inc. (LSTA)
3.27
+0.07
(+2.19%)
USD |
NASDAQ |
May 27, 14:48
Lisata Therapeutics Free Cash Flow : -13.66M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Protalix Biotherapeutics, Inc. | 13.00M |
| Agenus, Inc. | -87.53M |
| Curis, Inc. | -28.95M |
| Plus Therapeutics, Inc. | -21.72M |
| Windtree Therapeutics, Inc. | -15.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.083M |
| Cash from Financing (Quarterly) | 0.181M |
| Free Cash Flow Per Share (Quarterly) | -0.3423 |
| Free Cash Flow to Equity (Quarterly) | -3.083M |
| Free Cash Flow to Firm (Quarterly) | -3.083M |
| Free Cash Flow Yield | -47.49% |